Microbiome Impact on Immune Recovery: A Research Overview

What the microbiome is

The microbiome is the collection of microorganisms that live on and in the human body. The largest and most-studied population resides in the gastrointestinal tract, where bacteria, archaea, viruses, and fungi exist in numbers comparable to the body's own cells. The bacterial component has been characterized most thoroughly through 16S rRNA gene sequencing and shotgun metagenomic methods.

The Human Microbiome Project, an NIH-funded effort that ran from 2007 to 2016, produced foundational data on healthy human microbiome composition across body sites. Subsequent work has explored variability, function, and disease associations.

A 2018 review in Nature by Lloyd-Price and colleagues summarized that healthy human microbiomes show substantial inter-individual variation but consistent functional capacities — different species can play similar roles. This functional redundancy is part of why "the healthy microbiome" is a moving target in research.

The gut-immune axis fundamentals

The gut harbors the largest concentration of immune tissue in the body. The gut-associated lymphoid tissue (GALT), including Peyer's patches and isolated lymphoid follicles, contains a substantial fraction of total lymphocytes. The intestinal epithelium and underlying immune cells are in constant interaction with microbial signals.

This anatomical fact has functional consequences. Microbial signals shape the development and maintenance of immune cell populations. Germ-free animals raised without microbes show profound immune abnormalities, including reduced Th17 cells, altered regulatory T cell populations, and impaired antibody responses. Reconstituting germ-free animals with specific bacterial communities can restore or alter these immune features in research models.

In humans, the gut microbiome influences:

• Immune cell development at barrier surfaces and systemically.
• Production of short-chain fatty acids (SCFAs — butyrate, propionate, acetate) that have immune-regulatory effects in research.
• Epithelial barrier integrity — the "leaky gut" research concept refers to compromised barrier function.
• Bile acid metabolism, which influences immune and metabolic pathways.
• Competition against pathogens at mucosal surfaces.

A 2020 review in Cell by Belkaid and Hand described how the microbiome shapes immunity at multiple developmental and functional levels.

Dysbiosis — what it means in research

"Dysbiosis" is a research term for altered microbiome composition associated in studies with various diseases. It does not have a strict clinical definition. Studies typically describe dysbiosis in three ways:

• Reduced alpha diversity (fewer different species in a sample).
• Shifted composition (different relative abundances of major groups, e.g., Firmicutes-to-Bacteroidetes ratio).
• Altered functional capacity (changes in the metabolic potential of the community).

The term is descriptive, not diagnostic. There is no single "healthy" microbiome. Different populations, diets, and individuals harbor different communities that can all support health.

Microbiome research in post-viral conditions

Dietary patterns researchers discuss

The strongest evidence base in microbiome research is for dietary patterns rather than individual foods. The themes recurring across studies:

• Diverse plant intake. Research suggests eating many different plant species supports microbial diversity. The American Gut Project — a citizen-science effort — found that participants eating 30+ different plants per week had measurable microbiome differences from those eating 10 or fewer.
• Adequate fiber. Fiber from whole grains, vegetables, fruits, and legumes feeds fiber-fermenting bacteria that produce SCFAs.
• Lower ultra-processed-food intake. Several studies link high ultra-processed-food intake with lower microbial diversity.
• Mediterranean-style dietary pattern. Repeatedly associated with favorable microbiome profiles in observational studies.

See our anti-inflammatory diet overview for the broader research framing of these patterns.

Fermented foods in research

Fermented foods — yogurt, kefir, sauerkraut, kimchi, miso, tempeh — contain live microbes and microbial metabolites. A 2021 paper in Cell by Wastyk and colleagues at Stanford randomly assigned healthy adults to a high-fiber diet or a high-fermented-food diet. The fermented-food group showed increased microbial diversity and decreases in some inflammatory markers; the fiber group showed less change in this short-term study. The authors framed findings as hypothesis-generating, not as a treatment recommendation.

The research suggests fermented foods can affect the microbiome, though the specific effects depend on the food, the person, and the baseline. Fermented foods are part of many traditional dietary patterns globally.

Polyphenols and the microbiome

Polyphenols are plant compounds found in fruits, vegetables, tea, coffee, cocoa, and red wine. Most dietary polyphenols are not absorbed in the small intestine; they reach the colon and are metabolized by gut bacteria into bioactive metabolites. A 2020 review in Nutrients by Cardona and colleagues summarized this two-way interaction: polyphenols shape the microbiome, and the microbiome shapes polyphenol bioactivity.

This is part of why studying individual polyphenols (such as quercetin or EGCG) outside of dietary context can miss important biology. The research community increasingly examines whole-diet patterns rather than isolated compounds.

Probiotics: research overview

Probiotics are live microorganisms that, when consumed in adequate amounts, are claimed to confer a health benefit. The probiotic market is large and often outpaces the evidence for specific products.

Specific strains have research bases for specific indications:

• Saccharomyces boulardii for antibiotic-associated diarrhea and Clostridioides difficile prevention has supporting evidence.
• Certain Lactobacillus and Bifidobacterium strains have evidence for acute infectious diarrhea, atopic dermatitis in infants, and irritable bowel syndrome symptoms in some studies.
• Akkermansia muciniphila is studied in metabolic-health research.

General "probiotic supplement" use for post-viral recovery does not have a consistent peer-reviewed evidence base. Different strains do different things. A "probiotic" without strain identification is mostly marketing.

Probiotics are generally well-tolerated in healthy adults but have specific safety considerations in immunocompromised people, critically ill patients, and infants. Discuss probiotic use with your healthcare provider, especially in these populations.

What this does not mean

• This is not a diagnostic article. GI symptoms have many causes — some require evaluation.
• This is not a recommendation for any specific probiotic or supplement.
• This is not evidence that one diet works for everyone.
• This is not a substitute for clinical evaluation by a licensed clinician.

Questions to ask your doctor

• "I have persistent GI symptoms after [infection]. Does evaluation make sense?"
• "What standard workup would you recommend?"
• "Should I see a gastroenterologist?"
• "Is a probiotic appropriate for me, given my [conditions/medications]?"
• "What dietary changes do you recommend for my situation?"

Authoritative sources to read directly

• NIH NIAID: Microbiome research
• NIH NIDDK: Digestive diseases
• CDC Long COVID
• Mayo Clinic: Probiotics overview
• Cleveland Clinic: Probiotics
• Harvard Nutrition Source: Microbiome

Related reading on this site